Universal screening for familial hypercholesterolaemia: how can we maximise benefits and minimise potential harm for children and their families?
December 1, 2024 | Screening for FH, Publication, Paediatric Lipid Working Group
Universal Screening programmes to identify subjects with FH have been the subject of much recent interest. However, any screening programme can cause harm as well as having potential benefits. Here we review recent papers using different ages and strategies to identify subjects with FH, and examine to what extent the publications provide quantitative or qualitative evidence of benefit or harm to children and adults.
- Curr Opin Lipidol. 2024 Dec 1;35(6):268-274
- PMID: 39364888
- doi: 10.1097/MOL.0000000000000952
- Download here >